Diagnostic and Interventional Cardiology

BioVentrix Announces Publication of Positive One-Year Outcomes for Revivent TC System

December 18, 2019 — BioVentrix, Inc., developer of the first less invasive system for left ventricular remodeling, today ...

December 18, 2019

News | Cath Lab

Cook Medical Recalls CrossCath Support Catheters Due to Marker Bands Dislodging

December 18, 2019 — Cook Medical initiated a recall of its CrossCath Support Catheters in November, which the U.S. Food ...

December 18, 2019

The most popular content in the month of November on DAIC was by far the data from the late-breaking trials from the American Herart Association (AHA) 2019 meeting. The second item on this month's list is an overview of key heart failure takeaways from AHA by Nasrien Ibrahim, M.D., associate director of resynchronization and advanced cardiac therapeutics at Massachusetts General Hospital. Photo by Scott Morgan/AHA.

Feature

December 16, 2019 — Here is the list of the most popular content on the Diagnostic and Interventional Cardiology (DAIC) ...

December 17, 2019

Sponsored Content

ASCEND provides the tools that not only address the unique needs of each cardiovascular subspecialty and to care for patients from infancy into their golden years, they also innovates next-generation solutions and services that empower the provider community to truly transform their cardiovascular services

Feature | Information Technology

SPONSORED CONTENT: Unveiling the Future of Cardiovascular Workflow

Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...

March 21, 2024

Vascepa pill contains a concentrated form of fish oil, icosapent ethyl, indication for prevention. The U.S. Food and Drug Administration (FDA) Dec. 13, 2019, approved the use of Vascepa (icosapent ethyl) capsules as an adjunctive therapy to reduce the risk of cardiovascular events in adults with elevated triglyceride levels.

Feature | Pharmaceuticals | Dave Fornell, Editor

FDA Expands Vascepa to Reduce Cardiovascular Events in Elevated Triglyceride Patients

The U.S. Food and Drug Administration (FDA) approved the use of Vascepa (icosapent ethyl) capsules as an adjunctive therapy to reduce the risk of cardiovascular events in adults with elevated triglyceride levels

December 16, 2019

impulse dynamics Optimizer for Heart failure.

News | Heart Failure

Impulse Dynamics Secures $80.25 Million Financing

December 12, 2019 — Impulse Dynamics, developer of Optimizer Smart System for delivering CCM therapy, announced the ...

December 12, 2019

News | Antiplatelet and Anticoagulation Therapies

Low-dose Aspirin May Not Help African Americans Prevent Heart Disease

December 12, 2019 — Low-dose aspirin was not associated with a reduced risk of a fatal heart attack among African ...

December 12, 2019

Sponsored Content

Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability to diagnose cardiac disease with greater accuracy and precision

Feature | Cardiac Imaging

SPONSORED CONTENT: Finding the Right Solution

Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...

March 05, 2024

News | ECG

Cardiologs Earns Frost & Sullivan’s New Product Innovation Award

December 12, 2019 — Cardiologs, a global leader in artificial intelligence (AI) cardiology diagnostics, announced today ...

December 12, 2019

DiA’s novel solution leverages AI to transform the way clinicians capture and analyze ultrasound images

News | Cardiac Imaging

DiA Joins with IBM Watson Health to Arm Clinicians with its AI-powered Cardiac Ultrasound Software

December 9, 2019 — DiA Imaging Analysis Ltd., an IBM Alpha Zone Accelerator Alumni Startup, announces a collaboration ...

December 09, 2019

CAE Healthcare will showcase its mixed reality training solutions for practicing physicians and medical imaging companies for the first time at the Radiological Society of North America (RSNA) 2019 meeting. With technology platforms that integrate modeled human physiology into immersive, augmented reality environments, CAE Healthcare partners with vendors to deliver risk-free training solutions that meet the needs of physicians and equipment providers. #RSNA19 #RSNA2019

News | Virtual and Augmented Reality

Augmented Reality for Radiology and Cardiology Training Demonstrated at RSNA 2019

November 27, 2019 — CAE Healthcare will showcase its mixed reality training solutions for practicing physicians and ...

November 27, 2019

Sponsored Content

Blog

BLOG: Combining Local Impedance with Contact Force to Perform RF Ablation

When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...

December 11, 2023

A sample of the transcatheter mitral valve replacement (TMVR) devices in development or clinical trials.

Feature | Heart Valve Technology | Saipriya Iyer

Developments in Transcatheter Mitral Valve Replacement

The overwhelming success story for transcatheter aortic valve replacement (TAVR) moving from a science project to ...

November 27, 2019

The Philips Lumify hand-held ultrasound technology is an important component of the mobile ECMO unit. Members of the ECMO team use Lumify for real-time visual guidance when inserting tubes in veins and arteries in a process called ECMO cannulation. #RSNA2019 #RSNA19 #POCUS

Feature | Ultrasound Imaging

Handheld Ultrasound Aids First Mobile ECMO Unit in a Pre-hospital Setting

November 26, 2019 — Physicians from the University of New Mexico (UNM) and local emergency responders recently treated a ...

November 26, 2019

A key slide from the TRILUMINATE study one-year results showing the improvement in tricuspid regurgitation from basement with treatment using the transcatheter TriClip device.

News | Heart Valve Technology | Dave Fornell, Editor

TriClip Device For Tricuspid Regurgitation Effective at One Year in TRILUMINATE Study

November 26, 2019 — The preliminary one-year results of the TRILUMINATE Pivotal Study for Abbott's TriClip device, a ...

November 26, 2019

Sponsored Content

Case Study | Hemodynamic Monitoring Systems

TECH BRIEF — Integrated Hemodynamic Monitoring System Helps Improve Lab Performance, Efficiency

Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...

November 14, 2023

News | Cardiovascular Clinical Studies

Virtual Study to Track Statin-Related Adverse Events Being Undertaken by University of Connecticut and Hartford Healthcare

November 26, 2019 — The University of Connecticut (UConn) Department of Kinesiology and Hartford Healthcare have ...

November 26, 2019

The FDA cleared the IN.PACT AV drug-coated Balloon. Clinical data shows In.Pact AV DCB is Safe, reduces reinterventions and maintains access for end-stage renal disease patients undergoing dialysis

News

FDA Clears Medtronic Drug-Coated Balloon to Treat Arteriovenous Fistula Lesions

The U.S. Food and Drug Administration (FDA) has cleared the Medtronic In.Pact AV drug-coated balloon (DCB) for the treatment of failing arteriovenous (AV) access in patients with end-stage renal disease (ESRD) undergoing dialysis.

November 26, 2019

News | AHA

Artificial Intelligence Examining ECGs Predicts Irregular Heartbeat, Death Risk

November 22, 2019 — Artificial intelligence can examine electrocardiogram (ECG) test results, a common medical test, to ...

November 22, 2019